title: [Paclitaxel should be included in standard therapy of ovarian carcinoma].
authors: Radiumhospitalet, Oslo. c.g.trope@klinmed.uni.no
authors: Claes
authors: C
authors: Tropé
authors: Janne
authors: J
authors: Kaern
authors: Gunnar
authors: G
authors: Saeter
authors: Martin
authors: M
authors: Gore
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel